Australia-based radiopharmaceutical company Telix Pharmaceuticals has created a new radionuclide generator that could facilitate the commercial supply of lead-212 isotope-based therapies.

Bank of America Global Healthcare Conference Date: Tuesday, May 13, 2025 Format: Fireside Chat Time: 11:35 a.m. – 11:50 a.m. PT / 2:35 p.m. – 2:50 p.m. ET Location : Las Vegas, NV 2025 RBC Capital ...

The NASA/ESA Solar Orbiter recently recorded the highest-ever concentration of a rare helium isotope (3 He) emitted from the sun. A Southwest Research Institute-led team of scientists sought the ...

Perspective Therapeutics, Inc. (“Perspective” or the “Company”) (NYSE AMERICAN: CATX), a radiopharmaceutical company pioneering advanced treatments for cancers throughout the body, today announced ...